g(s)

Tryptamines
5-MeO-DiPT HCl. Powder

QUANTITYPRIC PER gSAVE AMOUNT
1 to 1 EUR 69.00 /g 0%
2 to 2 EUR 58.65 /g 15%
3 to 4 EUR 44.85 /g 35%
5 to 9 EUR 37.95 /g 45%
10 to 24 EUR 31.05 /g 55%
25 to 49 EUR 27.60 /g 60%
50 to 99 EUR 24.15 /g 65%
100 + EUR 20.70 /g 70%

POPULAR PRODUCT
Many customers bought this product recently.


Available
Now
Stealth
Packaging
Cheapest
price

5-MeO-DiPT HCl. Powder


5-Methoxy-N,N-diisopropyltryptamine, commonly known as 5-MeO-DiPT, Foxy, or Foxy Methoxy, is a novel psychedelic substance within the tryptamine class that produces psychedelic effects upon administration. It is structurally related to other compounds such as DiPT and 5-MeO-MiPT.


Historical Background

The first human trials of 5-MeO-DiPT were conducted by the renowned chemist Alexander Shulgin in 1975. He later co-authored a paper detailing its synthesis and psychopharmacology, published in 1981. A summary of the synthesis and reports of human use can be found in Shulgin's influential 1997 book, TiHKAL ("Tryptamines I Have Known And Loved").


Effects and User Experience

Anecdotal reports characterize the effects of 5-MeO-DiPT as highly stimulating and mildly entactogenic, with a notable absence of typical psychedelic visual distortions. Many users report strong physical and tactile sensations that enhance libido and sexual pleasure. However, higher dosages are often accompanied by an unpleasant body load. Additionally, some users experience sound distortion, a phenomenon also noted with the related compound DiPT.


Chemical Structure

5-MeO-DiPT is a synthetic indole alkaloid that features a core structure typical of tryptamines, characterized by a bicyclic indole heterocycle attached at the R3 position to an amino group via an ethyl side chain. This compound is specifically substituted at the R5 position of its indole heterocycle with a methoxy (MeO) functional group (CH3O−) and contains two isopropyl chains bound to the terminal amine (RN) of its tryptamine backbone, making it the N-substituted diisopropyl homologue of 5-MeO-MiPT.


Pharmacological Mechanism

The mechanism underlying the purported hallucinogenic and entheogenic effects of 5-MeO-DiPT is thought to primarily involve agonism at the 5-HT2A receptor. Additionally, other mechanisms of action, such as monoamine oxidase inhibition (MAOI), may also play a role. Notably, 5-MeO-DiPT exhibits the strongest receptor binding affinity at the 5-HT1A receptor.


5-MeO-DiPT HCl. Powder is for research use only and not intended for human consumption!


5-MeO-DiPT HCl. Powder stock last updated at: April 2025